Drugs / P-3074
last change Mar 2018 re-read 2 minutes ago

P-3074

Developed for
androgenetic alopecia
Investigated by
Polichem S.A.

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03004469 Aug 2016 → Mar 2018 androgenetic alopecia Polichem S.A. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as P-3074 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03004469
Route Topical topical application of P-3074 contained finasteride 0.25% in morning onto dry scalp only (up to 4 puffs)” NCT03004469